Industry-specific guidance · 7 sectors
Industry guidance
Research-administration standards differ in emphasis across industries — pharmaceutical R&D operates inside ICH GCP + FDA; biotech adds IP-preserving disclosure; academic medical centres weave clinical care with research. CASRAI vocabulary cuts across these conventions so the same dictionary serves every actor.
By industry
Pick your sector
Life sciences
Pharmaceutical research
Pharmaceutical R&D — from target discovery through Phase IV — operates inside a dense web of research-administration standards: ICMJE authorship, CRediT for contributions, ICH GCP for trials, NSPM-33 + EU AI Act for AI use, and increasingly tight data-sharing mandates from FDA, EMA, and major funders. CASRAI vocabulary bridges the gap between investigator-initiated and sponsored research conventions.
~$1.6T global market (2024)
Industry guidance →Life sciences
Biotechnology
Biotech R&D — across cell + gene therapy, synthetic biology, computational biology, and platform technologies — increasingly relies on academic-industry collaborations, pre-competitive consortia, and data-deposit mandates from journals and funders. CASRAI standards help biotech firms publish responsibly, attribute contributions cleanly, and meet open-data requirements without compromising IP.
~$1.5T global market (2024)
Industry guidance →Life sciences
Medical device industry
Medical-device R&D — across diagnostics, therapeutics, implants, software-as-medical-device (SaMD), and AI-enabled devices — operates inside FDA 21 CFR, EU MDR / IVDR, and increasingly under FDA AI/ML Action Plan + EU AI Act. Investigator-initiated studies often produce peer-reviewed publications requiring CRediT, ICMJE, and ORCID compliance.
~$590B global market (2024)
Industry guidance →Life sciences
Contract Research Organisations
Contract Research Organisations sit between sponsors and investigators on most clinical trials — running operations, biostatistics, medical writing, data management, and regulatory submissions. Increasingly the CRO contribution to peer-reviewed publications must be attributed properly under CRediT and ICMJE; medical-writer disclosure (via EMWA / ISMPP / GPP3) is a regulatory expectation.
~$80B global CRO market (2024)
Industry guidance →Higher education · health
Academic Medical Centres
Academic Medical Centres (AMCs) integrate clinical care, education, and research — a uniquely complex research-administration environment. AMC researchers navigate NIH funding, IRB review, ACGME-aligned trainee attribution, clinical-trial registration, and CRediT-aware publication conventions all at once. CASRAI standards provide the shared vocabulary to thread these together.
AAMC: 158 US AMCs + 800+ teaching hospitals
Industry guidance →Government · National labs
Government research laboratories
Government research laboratories — US Department of Energy national labs, NASA centres, UK Catapults, EU Joint Research Centre, Australia's CSIRO, Germany's Helmholtz / Fraunhofer / Max Planck — produce a substantial fraction of national scientific output. Distinct from university research, they operate under additional mandates around classified work, export control, dual-use, and inter-agency reporting.
US: 17 DOE national labs; UK: ~10 Catapults; EU: JRC
Industry guidance →Non-profit research
Independent research institutes
Independent research institutes — Wellcome Sanger, Broad Institute, Crick, Karolinska, RIKEN, Allen Institute, Salk, Stowers, Whitehead, and hundreds of smaller institutes worldwide — operate as research-only organisations outside the university and government-lab structures. They are heavy CRediT adopters and often pioneer open-data practices.
Global: thousands of independent research institutes
Industry guidance →
